New Psilocybin Microdosing Data: How Much is Too Much?
Real-time gathering of physiological data and subjective effects give clues that may help define a microdose of psilocybin.
Scientific Research - Page 21
Female Hormones, 5-HT2A Receptors, and Psychedelics
Female hormones affect binding at the 5-HT2A receptor. Does this mean there is a uniquely female entourage effect with psychedelics?
Usona Follows COMPASS in Receiving Breakthrough Therapy Designation for Psilocybin to Treat Depression
This means the FDA will work to expedite the development and review of psilocybin so it can get to patients with major depressive disorder as soon as possible.
The Serotonin Receptors: An Overview and Their Importance in Psychedelic Research
From constipation to cognition, serotonin receptors play many roles in addition to the psychedelic effect.
Scientists Discover New Compounds in Magic Mushrooms
Researchers isolate ß-carbolines from several species of Psilocybe.
Psychedelics as Anti-Inflammatory Agents
A look into the less discussed therapeutic aspect of psychedelics: the anti-inflammatory effect.
Scientists Solve the Crystal Structure of the Fumarate Salts of DMT and Psilocin Derivatives
This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
Jamaica is Home to the First Magic Mushroom Research Center
The center aims to quantify the chemicals in magic mushrooms and possibly identify new psychedelic molecules in them.
Scientists Engineer E. Coli to Produce Psilocybin
This is the first time psilocybin has been produced from a prokaryotic organism.
Usona Institute Beginning Phase 2 Clinical Trials Using Psilocybin to Treat Major Depressive Disorder
Enrollment of study volunteers is expected to start within the next two months.